The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: etoposide     Quarter: 2016Q3

Total Records: 893     Number of Pages: 45

DRUGNAME PT EventCount
ETOPOSIDE TEVA Staphylococcal infection 1
ETOPOSIDE TEVA Thrombocytopenia 1
ETOPOSIDE TEVA - TEVA PHARMA B.V. Chest discomfort 1
ETOPOSIDE TEVA - TEVA PHARMA B.V. Dyspnoea 1
ETOPOSIDE TEVA - TEVA PHARMA B.V. Generalised erythema 1
ETOPOSIDE TEVA - TEVA PHARMA B.V. Hyperhidrosis 1
ETOPOSIDE TEVA - TEVA PHARMA B.V. Infusion related reaction 1
ETOPOSIDE TEVA 20 mg/ml Acute kidney injury 1
ETOPOSIDE TEVA 20 mg/mL Bone marrow failure 1
ETOPOSIDE TEVA 20 mg/ml Febrile bone marrow aplasia 1
ETOPOSIDE TEVA 20 mg/mL Off label use 1
ETOPOSIDE TEVA 20 mg/mL Pyrexia 1
ETOPOSIDE TEVA 20 mg/ml Septic shock 1
ETOPOSIDE TEVA 20 mg/mL Stomatitis 1
ETOPOSIDE TEVA 200 MG Bronchospasm paradoxical 1
ETOPOSIDE TEVA 200 MG Pyrexia 1
ETOPOSIDE TEVA 200 MG Respiratory distress 1
ETOPOSIDE TEVA 20mg/ml Bone marrow failure 1
ETOPOSIDE TEVA 20mg/ml Staphylococcal bacteraemia 1
ETOPOSIDE-TEVA Drug-induced liver injury 1

Total Records: 893     Number of Pages: 45